Literature DB >> 1425793

Polymerase chain reaction-amplification of urease genes: rapid screening for ureaplasma urealyticum infection in endotracheal aspirates of ventilated newborns.

W Scheurlen1, G Frauendienst, L Schrod, H B von Stockhausen.   

Abstract

Ureaplasma urealyticum infection has been considered to play an important role in the development of bronchopulmonary dysplasia (BPD) in premature infants. Since standard culture methods of U. urealyticum are difficult to perform, new rapid and sensitive methods are needed to detect lung infection of ventilated newborns. Here we describe the polymerase chain reaction as a rapid method to screen endotracheal aspirates for ureaplasma infection. Urease-specific sequences could only be detected in 1 out of 36 ventilated newborns. The procedure described in this paper may facilitate further studies to determine the role of U. urealyticum in development of BPD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425793     DOI: 10.1007/bf01959080

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Chorioamnionitis and colonization of the newborn infant with genital mycoplasmas.

Authors:  P A Shurin; S Alpert; B A Bernard Rosner; S G Driscoll; Y H Lee
Journal:  N Engl J Med       Date:  1975-07-03       Impact factor: 91.245

2.  Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon.

Authors:  A Blanchard
Journal:  Mol Microbiol       Date:  1990-04       Impact factor: 3.501

3.  Role of Ureaplasma urealyticum in bronchopulmonary dysplasia.

Authors:  R B Holtzman; J R Hageman; R Yogev
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406

4.  Chorioamnionitis: perinatal morbidity and mortality.

Authors:  S G Driscoll
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

Review 5.  Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy.

Authors:  P T Rudd; K B Waites; L B Duffy; S Stagno; G H Cassell
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

6.  Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants.

Authors:  G H Cassell; K B Waites; D T Crouse; P T Rudd; K C Canupp; S Stagno; G R Cutter
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

7.  The male reservoir of Ureaplasma urealyticum.

Authors:  D Taylor-Robinson
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

8.  Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants.

Authors:  P J Sánchez; J A Regan
Journal:  Pediatr Infect Dis J       Date:  1988-08       Impact factor: 2.129

Review 9.  Role of Ureaplasma urealyticum in amnionitis.

Authors:  G H Cassell; K B Waites; R S Gibbs; J K Davis
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

Review 10.  Is genital colonization with Mycoplasma hominis or Ureaplasma urealyticum associated with prematurity/low birth weight?

Authors:  R Romero; M Mazor; E Oyarzun; M Sirtori; Y K Wu; J C Hobbins
Journal:  Obstet Gynecol       Date:  1989-03       Impact factor: 7.661

View more
  4 in total

1.  Comparison of the Mycoplasma Duo test with PCR for detection of ureaplasma species in endotracheal aspirates from premature infants.

Authors:  Fook-Choe Cheah; Trevor P Anderson; Brian A Darlow; David R Murdoch
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Detection of Ureaplasma urealyticum in endotracheal tube aspirates from neonates by PCR.

Authors:  S Nelson; A Matlow; G Johnson; C Th'ng; M Dunn; P Quinn
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 3.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 4.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.